Adverse drug reactions in old age

Adverse Drug Reaction Bulletin

Volumn , Issue 237, 2006, Pages 907-910

  Wynne, Hilary A ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; CARDIOVASCULAR AGENT; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOOXYGENASE 2 INHIBITOR; CYTOTOXIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; INSULIN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; POTASSIUM SPARING DIURETIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; THIONAMIDE; WARFARIN;

AKATHISIA; BLEEDING; BLOOD DYSCRASIA; BODY WEIGHT; BRADYCARDIA; CLINICAL TRIAL; CONFUSION; DIARRHEA; DRUG ABUSE; DRUG COST; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG INFORMATION; DRUG MONITORING; DRUG OVERDOSE; DRUG POTENTIATION; DRUG SURVEILLANCE PROGRAM; ELDERLY CARE; EPIGASTRIC PAIN; EUPHORIA; GASTROINTESTINAL HEMORRHAGE; HALLUCINATION; HEALTH CARE COST; HEMATOLOGIC DISEASE; HUMAN; HYPOGLYCEMIA; HYPONATREMIA; HYPOTENSION; INCIDENCE; INFORMATION DISSEMINATION; LENGTH OF STAY; MEDICAL DECISION MAKING; META ANALYSIS; MONOTHERAPY; MOTOR PERFORMANCE; NAUSEA; NEUTROPHIL DYSCRASIA; NURSING HOME; PARKINSONISM; PATIENT EDUCATION; PATIENT MONITORING; PLASMA CELL DYSCRASIA; POLYPHARMACY; QUALITY OF LIFE; RASH; RESPIRATION DEPRESSION; REVIEW; RISK ASSESSMENT; SELF MEDICATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; STOMACH PAIN; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; URTICARIA; VISUAL DISORDER;

EID: 33845987034     PISSN: 00446394     EISSN: None     Source Type: Journal    
DOI: 10.1097/00012995-200604000-00001     Document Type: Review

References (31)

1. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Internal Medicine Journal 2001; 31:199-205.
2. Wynne HA, Cope L, Mutch E, Rawlins MD, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9:297-301.
3. Epstein M. Effects of ageing on the kidney. Federation Proceeding 1979; 38:168-172.
4. Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA: Journal of the American Medical Association 2002; 287:2215-2220.
5. Speirs C, Wagniart F, Poggi L. Perindopril post marketing surveillance: a 12 month study in 47,351 hypertensive patients. British Journal of Clinical Pharmacology 1998; 46:63-70.
6. Bennett CL, Nebeker JR, Lyons EA, et al. The research on adverse drug events and reports (RADAR) report. JAMA: Journal of the American Medical Association 2005; 293:2131-2140.
7. Waller P, Shaw M, Ho D, et al. Hospital admission for 'drug induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. British Journal of Clinical Pharmacology 2005; 59:213-219.
8. Lazarou J, Pomeranz BH, Covey PW. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA: Journal of the American Medical Association 1998; 279:1200-1205.
9. Beijer HJM, De Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharmacy World & Science 2002; 24:46-54.
10. Burgess CL, Holman CD, Satti AG. Adverse drug reactions in older Australians, 1981-2002. Medical Journal of Australia 2005; 182:267-270.
11. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329:15-19.
12. Wilcox CM, Cruer B. Patterns of use and public perception of over-the-counter pain relievers: focus on non-steroidal anti-inflammatory drugs. Journal of Rheumatology 2005; 32:2218-2224.
13. Letrilliart L, Hanslik T, Biour M, et al. Post discharge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study. Drug Safety 2001; 24:781-792.
14. Veehof LJ, Stewart RE, Meyboom de Jong B, Haaijer-Ruskamp FM. Adverse drug reactions and polypharmacy in the elderly in general practice. European Journal of Clinical Pharmacology 1999; 55:533-536.
15. Cooper JW. Adverse drug reactions: related hospitalisations of nursing facility patients: a 4 year study. Southern Medical Journal 1999; 92:485-490.
16. Suh DC, Woodall BS, Shin SK, Hermes De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalised patients. Annals of Pharmacotherapy 2000; 34:1373-1379.
17. Biswasl PN, Wilton LV, Pearcel GL, et al. The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. Journal of Psychopharmacology 2001; 15:265-271.
18. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Safety 1999; 20:277-287.
19. Castleden CM, Pickles H. Suspected adverse drug reactions in elderly patients reported to the Committee on Safety of Medicines. British Journal of Clinical Pharmacology 1988; 26:347-353.
20. Pearce SH. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clinical Epidemiology 2004; 61:589-594.
21. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as a cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). Journal of the American Geriatrics' Society 2002; 50:1962-1968.
22. Onder G, Gambassi G, Scales CJ, et al. Adverse drug reactions and cognitive function among hospitalized older adults. European Journal of Clinical Pharmacology 2002; 58:371-377.
23. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA: Journal of the American Medical Association 2003; 289:1652-1658.
24. Battistella M, Mamdami M, Juurlink DN, et al. Risk of upper gastrointestinal hemorrhage in warfarin users treated with non-selective NSAIDs of COX-2 inhibitors. Arch Intern Med 2005; 165:189-192.
25. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157:1531-1536.
26. Onder G, Landi F, Cesari M, et al. Inappropriate medication use among hospitalised older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. European Journal of Clinical Pharmacology 2003; 59:157-162.
27. Winterstein AG, Hatton RC, Gonzalez-Rothi R, et al. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. American Journal of Health-System Pharmacy 2002; 59:1742-1749.
28. Hippius M, Humaid B, Sicker T, et al. Adverse drug reaction monitoring: digitoxin overdose in the elderly. International Journal of Clinical Pharmacology and Therapeutics 2001; 39:336-343.
29. Winterstein AG, Sauer BC, Hapler CD, Poole C. Preventable drug-related hospital admissions. Annals of Pharmacotherapy 2002; 36:1238-1248.
30. Kanjanarat P, Winterstein AG, Johns TE, et al. Nature of preventable adverse drug events in hospital: a literature review. American Journal of Health-System Pharmacy 2003; 60:1750-1759.
31. Green CF, Mottram DR, Pirmohamed M, et al. Communication regarding adverse drug reactions between secondary and primary care: a postal questionnaire survey of general practitioners. Journal of Clinical Pharmacy and Therapeutics 1999; 24:133-139.